Explore
Clinical Features and Long-Term Outcomes of Systemic Lupus Erythematosus
0 Ungluers have
Faved this Work
Login to Fave
The clinical spectrum of systemic lupus erythematosus (SLE) is highly heterogeneous, ranging from mild disease, which can be limited to skin and joint involvement, to life-threatening conditions with renal impairment, severe cytopenias, central nervous system disease, and thromboembolic events. Apart from the host genetics, several environmental factors, such as sunlight, infections, drugs, and probably hormonal factors, can trigger the onset of symptoms related to SLE. Despite significant advances in our understanding of the pathophysiology and optimization of medical care, patients with SLE still have significant rates of premature mortality and many patients experience severe disease with increased risk of sustaining organ damage and having a reduced health-related quality of life. The development of effective drugs that can induce remission or low disease activity, the unanimous use of definitions of remission and low or high disease activity, flare, and response to therapy, the identification of non-invasive biomarkers of disease activity and long-term outcomes, and the implementation of SLE patients’ perspectives as an integral part of the clinical assessment constitute only a few of the many unmet needs in the field of SLE.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 30 times via unglue.it ebook links.
- 30 - pdf (CC BY) at Unglue.it.
Keywords
- abnormal liver function tests
- afro-caribbean
- Autoantibodies
- autoimmune hepatitis
- autoimmune liver diseases
- Cancer
- Cardiovascular Disease
- chronic damage
- Classification
- clinical follow-up
- Cluster analysis
- comorbidities
- Compliance
- COVID-19
- cross-sectional studies
- damage
- dehydroepiandrosterone
- disease activity
- end-stage renal disease
- Epidemiology
- Fatigue
- flare
- Genetics
- Glucocorticoids
- health-related quality of life
- hepatic involvement
- hospital admissions
- hydroxychloroquine
- Infections
- Ki/SL
- Laboratory
- linear discriminant analysis
- Liver biopsy
- long disease duration
- long-term prognosis
- low disease activity
- low-disease activity
- lupus
- lupus nephritis
- medication adherence
- medicine
- MIR1279
- Mood Disorders
- Mortality
- n/a
- neoplasm
- outcome
- outcome measures
- Pain
- patient outcome
- patient perspective
- patient-reported outcomes
- polymorphisms
- primary biliary cholangitis
- proteasome
- psychosocial
- Qualitative research
- Quality of life
- remission
- Rheumatoid arthritis
- Sjögren syndrome
- SLE
- SLEDAI-2K
- surveys and questionnaires
- Survival
- systemic lupus
- systemic lupus erythematosus
- TNFSF4
- trajectories
Links
DOI: 10.3390/books978-3-0365-6109-7Editions